Plasma from COVID-19 survivors tested as treatment in terminated trial
NCT ID NCT04516811
First seen May 14, 2026 · Last updated May 19, 2026 · Updated 3 times
Summary
This study tested whether giving plasma (the liquid part of blood) from people who recovered from COVID-19 could help hospitalized patients with moderate to severe COVID-19 get better faster. The trial planned to enroll many adults, but was stopped early after including 102 participants. The main goal was to see if this treatment led to clinical improvement by day 28.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Mitchells Plain Hospital
Cape Town, Western Cape, 7786, South Africa
-
Universitas Hospital
Bloemfontein, Free State, 9301, South Africa
Conditions
Explore the condition pages connected to this study.